Latest filing published 02 May 2012 for SCICLONE PHARMACEUTICALS INC, €25.1M.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -49.5%Entry US$220.00 · Close at T+365 US$111.00
- -30.2%Entry US$315.00 · Close at T+365 US$220.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sigma TAU Finanziaria SpA: trading record in brief
Sigma TAU Finanziaria SpA is a declared insider at 3 companies; the most frequent names are Sciclone Pharmaceuticals Inc, Regenerx Biopharmaceuticals Inc and Soligenix, Inc. Over a trading history stretching from 6 March 2006 to 30 April 2012, the count stands at 33 filings.
Both buying and selling appear: 30 purchases worth €9.4M, against 1 sale worth €25.1M. Taken together, the sales exceed the purchases by €15.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. So far in 2012, the count stands at no purchases and 1 sale.
In size, the median ticket on the buying side is €36k.
Most recently, on 2 May 2012, the filings show an open-market sale worth €25.1M in Sciclone Pharmaceuticals Inc. The latest purchase dates back some time: it was published 5,785 days ago, on 7 January 2011. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sigma TAU Finanziaria SpA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,328,469 shares@ US$5.25Common StockSEC:0001104659-12-032076:0
- 252,469 shares@ US$5.25Common StockSEC:0001104659-12-032076:1
- 28,600 shares@ US$2.0491Common StockSEC:0001140361-08-002493:0Canonical exit: 29 Apr 2008 (T+90)
- 400 shares@ US$2.05Common StockSEC:0001140361-08-002252:0Canonical exit: 27 Apr 2008 (T+90)
- 4,200 shares@ US$2.05Common StockSEC:0001140361-08-002060:0Canonical exit: 23 Apr 2008 (T+90)
- 32,087 shares@ US$2.0449Common StockSEC:0001140361-08-002060:1Canonical exit: 24 Apr 2008 (T+90)
- 200 shares@ US$2.00Common StockSEC:0001140361-08-001861:0Canonical exit: 13 Apr 2008 (T+90)
- 7,035 shares@ US$2.0112Common StockSEC:0001140361-08-001862:0Canonical exit: 21 Apr 2008 (T+90)
- 22,098 shares@ US$2.0129Common StockSEC:0001140361-08-001862:1Canonical exit: 22 Apr 2008 (T+90)
- 50,976 shares@ US$2.0123Common StockSEC:0001140361-08-001505:0Canonical exit: 14 Apr 2008 (T+90)
- 12,353 shares@ US$2.0217Common StockSEC:0001140361-08-001505:1Canonical exit: 15 Apr 2008 (T+90)
- 28,001 shares@ US$1.9993Common StockSEC:0001140361-08-001355:0Canonical exit: 10 Apr 2008 (T+90)
- 400 shares@ US$2.00Common StockSEC:0001140361-08-001355:1Canonical exit: 13 Apr 2008 (T+90)
- 54,640 shares@ US$2.042Common StockSEC:0001140361-07-022136:0Canonical exit: 11 Feb 2008 (T+90)
- 16,684 shares@ US$2.048Common StockSEC:0001140361-07-021503:0Canonical exit: 5 Feb 2008 (T+90)
- 673 shares@ US$2.05Common StockSEC:0001140361-07-021503:1Canonical exit: 6 Feb 2008 (T+90)
- 40,255 shares@ US$2.046Common StockSEC:0001140361-07-021238:0Canonical exit: 3 Feb 2008 (T+90)
- 25,000 shares@ US$2.05Common StockSEC:0001140361-07-020943:0Canonical exit: 30 Jan 2008 (T+90)
- 29,119 shares@ US$2.048Common StockSEC:0001140361-07-020943:1Canonical exit: 31 Jan 2008 (T+90)
- 25,000 shares@ US$2.05Common StockSEC:0001140361-07-020257:0Canonical exit: 17 Jan 2008 (T+90)
- 25,000 shares@ US$2.0499Common StockSEC:0001140361-07-020071:0Canonical exit: 15 Jan 2008 (T+90)
- 16,269 shares@ US$2.05Common StockSEC:0001140361-07-020071:1Canonical exit: 16 Jan 2008 (T+90)
- 20,000 shares@ US$2.05Common StockSEC:0001140361-07-019927:0Canonical exit: 13 Jan 2008 (T+90)
- 50,000 shares@ US$2.059Common StockSEC:0001140361-07-019927:1Canonical exit: 14 Jan 2008 (T+90)
- 13,952 shares@ US$1.96Common StockSEC:0001140361-07-019178:0Canonical exit: 30 Dec 2007 (T+90)
25 of 29 declarations